(1 - 41 from 57
)
Serious side effects seen with failed Merck niacin drug -study -...
www.reuters.com
Professor Jane Armitage, who led the study called HPS2-Thrive, called the findings disappointing. “Still,” she said, “finding out a drug is not ...
Professor Jane Armitage | University of Oxford
www.ox.ac.uk
Professor Armitage’s main research interests are in lipids and the epidemiology of cardiovascular and other chronic diseases including osteoporosis. She also has particular experience in respiratory medicine, geriatrics and diabetes. She has co-ordinated and been chief investigator for a series
sorted by relevance / date